EGFR and cancer: In addition, alterations in FUTs’ mRNA expressions result in changes in the levels of Lewis antigen abundance, which interfere with various well-known cancer-associated signaling pathways including the PI3K/Akt [123] and EGFR/mitogen-activated protein kinase (MAPK) pathways [124].